Why Franklin Covey Stock Plummeted Today

Franklin Covey (FC) shares fell 12.9% on Thursday after the company reported Q3 FY2026 results (ended May 31) below Wall Street expectations and issued weaker-than-expected forward guidance. EPS was $0.27 on sales of $67.8M vs estimates of about $0.31 on ~$68.3M revenue; guidance called for $260M–$267M sales vs prior $265M–$275M.

Original reporting
Published Jul 2, 2026, 11:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 11:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Franklin Covey Stock Plummeted Today — source image
Decision brief

The 30-second read

$FCBearishMed
01

Why it matters

The key new information is a below-consensus earnings/revenue print and a guidance cut for FY sales, which directly explains the double-digit stock decline described for Thursday.

02

Market read

Guidance reduction and earnings miss are likely to drive estimate revisions and continued volatility in FC shares.

03

What to watch

The article doesn’t discuss margin drivers, backlog, or contract timing; traders may be able to reassess once management clarifies what’s behind the guidance reduction.

Relevance 8/10Novelty 8/10Timing: after-hours July 1 results and guidance; selloff into Thursday close

Background

Franklin Covey’s fiscal 2026 third quarter ended May 31; the company released results and forward guidance after the July 1 market close.

Company-level read

Ticker impact

$FCBearishHigh confidence
Context

Franklin Covey reported Q3 FY2026 EPS of $0.27 and revenue of $67.8M, both below consensus, and guided FY sales below prior range.

Expected impact

Bearish bias for the next few sessions as traders reprice FY revenue expectations and margin/earnings trajectory.

Evidence & confidence

The article provides concrete, time-relevant datapoints: below-consensus EPS/revenue and a guidance cut from $265–$275M to $260–$267M.

Market effects

Signals continued pressure on small-cap business-services/consulting demand expectations when guidance is trimmed.

Limited; move is primarily company-specific with broader indices described as flat/only mildly down.

Low; no cross-border deal, regulation, or macro shock tied to FC in the text.

Counterpoint

The revenue growth is modestly positive (~+1% YoY) and EPS improved vs the prior-year quarter, so the selloff may overreact to the guidance midpoint.

Key entities

  • Franklin Covey

    FC reported Q3 FY2026 EPS $0.27 on $67.8M sales and guided FY sales to $260M–$267M, below prior range and consensus.

Related articles

$FCMed

Franklin Covey (FC) Q4 2026 Earnings Call Transcript

Franklin Covey (FC) reported Q4 2026 growth in Enterprise North America, with invoiced amounts up 4% to $151.4M and deferred revenue up 17% to $59.2M. The company expects fiscal 2027 revenue and adjusted EBITDA growth, driven by a resilient core and successful go-to-market transformation. Education business is expected to return to growth, and AI trends support the company's durability.

$FCMed

Franklin Covey Co (FC) (Q4 2026) Earnings Call Highlights: Navigating Revenue Headwinds

Franklin Covey (FC) reported China as 2% of fiscal 2026 revenue, with a transition to a licensee model expected to reduce revenue by $2 million but remain EBITDA neutral. CFO Jesse guided to 45-50% of annual revenue in the first half of fiscal 2027, with restructuring savings increasing EBITDA through the year. CEO Paul Walker noted improved revenue retention and plans to expand the sales team by over 20%.

$FCMed

Franklin Covey Co. Q3 2026 Earnings Call Summary

Franklin Covey Co. reported Q3 2026 momentum driven by higher client retention/expansion and North America enterprise growth, including a third straight quarter of rising invoiced amounts. Services booking pace rose 25% YTD. Fiscal 2027 outlook calls for faster revenue growth and operating leverage, but revenue guidance was cut ~$6M due to timing, education budget, and geopolitical impacts; gross margin fell to 73.9% from 76.5%.

$FCMed

FRANKLIN COVEY REPORTS THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS

FRANKLIN COVEY CO (FC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Press Release 13907 S. Minuteman Drive, Suite 500 Draper, UT 84020 www.franklincovey.com FRANKLIN COVEY REPORTS THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS Consolidated Third Quarter Revenue Increases 1% to $67.8 Million Invoic